ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC

SupplyChainStudyKeyInformantInterview InformationSheet Greetings from the London School of Hygiene & Tropical Medicine and PSI/Uganda! With the approval of the Ministry of Health, we are conducting a study called the Supply Chain Study on the availability of antimalarial medicines throughout Uganda. The results of this studywillbeusedtoimprovetheavailabilityofmalariatreatment.Iwouldliketoinviteyou to participate in this study because we believe that your experience in the antimalarial businesscancontributemuchtoourunderstanding. Thequestionswillcover: YourroleinthesupplychainsforantimalarialsandRDTs TheoverallantimalarialandRDTsupplychains PriceandavailabilityofantimalarialsandRDTs Thepolicyandregulatoryenvironment. Wewilltakenotesduringtheinterview. Howlongwilltheinterviewtake? Theinterviewwithyoushouldtakeapproximately1hour. Arethereanydisadvantagesoradvantagesinvolvedintakingpart? There areno individualbenefitsto taking part, butinansweringour questionsyou willhelp improve our understanding of the antimalarial market, and so potentially benefit all Ugandans.Theonlydisadvantageforyouisthetimetocompletetheinterview. WhowillhaveaccesstotheinformationIgive? Wewouldlikeyourpermissiontoidentifyyoubyname,orotheridentifyinginformationlike the organization you work for, your business title, and your occupation. We would also like yourpermissiontoquotethisinterview. If you do not wish to be named or quoted, the information gathered from this interview is confidential and will be kept private. We will not share individual information about you with anyone beyond our research team.Instead, theknowledge gainedfromthisinterview willbesharedinsummaryform,withoutrevealingindividualsidentities.Yourdecisiontobe namedandquotedisvoluntary. WhatwillhappenifIrefusetoparticipate? Participation in this research is completely voluntary. You are freeto decide if you want to takepartinthisstudy.Ifyoudoagree,youcanstillchangeyourmindatanytime.Youcan refusetoansweranyspecificquestion,orstoptheinterviewatanypoint.Ifyouchoosenot to answer a question, stop the interview or not participate there will not be any negative implicationsforyou. WhatifIhaveanyquestions? Ifyou have any questions, you can ask themnow,duringthe interview orlater. If you wish toaskquestionslater,youmaycontactanyofthefollowingmembersofthestudyteam:

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
PeterBuyungo,ResearchDirector,PSIUganda,tel.+256312351100 SimonSensalire,DeputyResearchDirector,PSIUganda,tel.+256312351100 This proposal has been reviewed and approved by the Ethical Review Committee of Makerere University Medical School, which is a committee whose task is to make sure that researchparticipantsareprotectedfromharm.Iyouwouldliketocontactthem,pleasecall: Chairperson,EthicalReviewCommittee,MakerereMedicalSchool,tel+256414530020

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainStudyKeyInformantInterview CertificateofConsent I have been informed aboutthe research study entitled Supply Chain Study and have had the opportunity to ask questions. I consent voluntarily to participate in this study and understandthatIhavetherighttowithdrawfromtheinterviewatanytime. Consentforinterview:_____(MARXWITHanX) I agree to be identified by name and other indentifying information, such as the organization that I work for, my business title, and my occupation, and agree to have this interviewquotedinanypublicationsresultingfromthisresearch. Consenttobenamedandquoted:_____(MARXWITHanX) Printnameofparticipant: ____________________________________________ Outletname: ____________________________________________ Signatureormarkoftheparticipant: ____________________________________________ Date:________________ Day/month/year Iconfirmthat theindividual has been fully informedabout thestudy andhas givenconsent freely. ____________________________________________ Printnameofresearcher: Signatureofresearcher: ____________________________________________ Date:________________ Day/month/year

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainStudyKeyInformantInterviews InterviewGuide KeyInformantDetails Name: Organisation: Department/Unit: Position: Sector:PublicorPrivateorNGO: Typeoforganization: Address: Telephone: Mobile: Email: InterviewDetails InterviewerName: InterviewDate(dd/mm/yyyy): StartTime(hh:mm): InterviewLocation: Informationformsprovided: Consentobtained EndTime(hh:mm):

Lengthoftimewithorganization:

yesorno yesorno

TheSupplyChainforAntimalarials 1. Regardingtheintervieweesroleintheantimalarialsupplychain: a. Pleasetellmeaboutyourorganizationandtheroleitplaysinthesupplychain forantimalarials. b. Pleasetellmeaboutyourself,yourpositionintheorganization,andyourrole. 2. Regardingtheoverallantimalarialsupplychain: a. Whatarethemainlevelsoftheantimalarialsupplychain,andwhathappensat eachlevel? b. Whoarethemainactorsateachlevelofthesupplychain(i.e.businesses,NGOs, procurementagencies,internationalorganizations,anddonors)?

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
c. Whataretherolesandmainactivitiesofactorsateachlevelofthesupplychain? d. Roughlyhowmanybusinessesofeachtypearethere?Wherearetheylocated? e. Ateachlevelofthesupplychain,arecertainbusinessesresponsibleforamajor shareofthemarket? f. Dolistsofimporters,wholesalers,distributorsandoutletsatvariouslevelsexist? 3. Regardingthepriceandavailabilityofantimalarials. a. Pleasenamethemainantimalarialmedications(bothgenericandbrandnames) thatareavailableinthecountry.IfattheNationalDrugAuthority,doyouhavea listofallantimalarialsregisteredinthecountry? b. Asbestasyoucan,pleasetrytoestimatethesalesvolumeforeachbrand,class, preparation,therapeuticcategoryetc.oftheantimalarialsthatyoumentioned. c. Asbestasyoucan,pleasetrytoestimatetheretailpriceforeachbrand,class, preparation,therapeuticcategoryetc.oftheantimalarialsthatyoumentioned. d. Tothebestofyourabilityandbeingasspecificasyoucan,pleaseestimatethe pricemarkupsateachlevelofthesupplychain. e. Pleasecommentontheavailabilityoftheantimalarialsthatyoumentioned before.Forexample: i. Aresomeproductsmorereadilyavailablecomparedtoothers? ii. Aretherecurrentlyorhavethererecentlybeenproblemswiththe availabilityofantimalarials? TheSupplyChainforRDTs 4. RegardingtheintervieweesroleintheRDTsupplychain: a. PleasetellmeyourorganizationandtheroleitplaysinthesupplychainforRDTs. b. PleasetellmeaboutyourroleinthesupplychainforRDTs 5. RegardingtheoverallRDTsupplychain a. IsthesupplychainforRDTsdistinctfromthesupplychainforantimalarials? b. Whatarethemainlevelsofthesupplychain,andwhathappensateachlevel? c. Whoarethemainactorsateachlevelofthesupplychain(ie.businesses,NGOs, procurementagencies,internationalorganizations,anddonors)? d. Whataretherolesandmainactivitiesofactorsateachlevelofthesupplychain? e. Roughlyhowmanybusinessesofeachtypearethere?Wherearetheylocated? f. Ateachlevelofthesupplychain,arecertainbusinessesresponsibleforamajor shareofthemarket? g. Dolistsofimporters,wholesalers,distributorsandoutletsatvariouslevelsexist? 6. RegardingthepriceandavailabilityofRDTs. a. PleasenamethemainRDTsthatareavailableinthecountry? b. Asbestasyoucan,pleasetrytoestimatethesalesvolumeforeachbrand, producttype,etc.ofRDTthatyoumentioned. c. Asbestasyoucan,pleasetrytoestimatetheretailpricesforeachoftheRDT productsthatyoumentioned. d. Tothebestofyourabilityandbeingasspecificasyoucan,pleaseestimatethe pricemarkupsateachlevelofthesupplychain.

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
e. PleasecommentontheavailabilityofRDTSthatyoumentionedbefore.For example: i. Aresomeproductsmorereadilyavailablecomparedtoother? ii. Aretherecurrentlyorhavethererecentlybeenproblemswiththe availabilityofRDTs? PoliciesandRegulations 7. Issuingoflicenses,permits,andregistrationforimporters,wholesalers,distributes,and outlets a. Aretheredifferentcategoriesoflicensesforimporters,wholesalers,distributors andoutlets? b. Whataretheconditions,requirementsandprocessesof licensing/permits/registration?Whatisthefeestructurefor licenses/permits/registrations? c. Howmanylicenses,permitsorregistrationsweregrantedthisyear? d. Inyouropinion,howeasyordifficultisitforpotentialnewimporters, wholesalersordistributorstoenterthemarkets? e. Isthereaprobationaryperiodfornewentrants? f. Howoftenmustlicenses,permitsandregistrationsberenewed?Howmuchdoes renewalcost? g. Pleasecommentontheimplementationoftheseregulationsforimporters, wholesalers,distributors,andoutlets.Forexample, i. Isitcommonforbusinessestooperatewithouttheappropriatelicense? ii. Whydosomebusinesseschoosetooperatewithouttheappropriate license? iii. Whatwouldyouchangeaboutlicensingandregistrationarrangementsor processes? 8. TaxesandTariffs a. Pleasedescribethemaintaxesthatmustbepaidbyactorsateachlevelofthe supplychainforantimalarials. b. Doesthetaxstatusofantimalarialsdifferfromotherdrugs?How? c. Pleasedescribethemaintaxesthatmustbepaidbyactorsateachlevelofthe supplychainforRDTs. d. Howarethetaxratesset? e. Howarethesetaxespaid? f. Whatrecordsofgoodsboughtand/orincomemustbekeptfortaxation purposes g. Whatarethecosts(officialandunofficial)ofobtainingclearancefor antimalarials? h. Pleasecommentontheimplementationoftaxesandtariffs? i. Arethereanyproblemswithtaxesnotbeingpaid? ii. Whatimpactdotaxeshaveonthesupplychainforantimalarials? iii. Whatwouldyouchangeaboutthesetaxes? 9. Regulations

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
a. Whatarethemaindocumentsregulatingthesupplychainforantimalarials? b. Pleasedescribethemainpoliciesandregulationsthatdictatetheactivitiesof actorsateachlevelofthesupplychainforantimalarials. c. Pleasedescribethemainpoliciesandregulationsthatdictatetheactivitiesof actorsateachlevelofthesupplychainforRDTs d. Arethereanyregulationsabouthowthedrugsarekeptordispensed,orthe typesofpackagingallowed? e. Arethereotherregulationsforbusinessesrelatedtotheiroperation(ex.staffing, building,etc)? f. Howiscompliancewithregulationsofantimalarialmarketsenforcedand monitored? i. Whattypeofinspectionsareconductedateachlevelofthesupplychain? ii. Howoftenareinspectionsconducted?(intheoryandinpractice) g. Whataresomeofthefindingsfromrecentinspections? h. Pleasecommentontheeffectivenessoftheseregulations.Forexample: i. Isitcommontofindbusinessesfloutingtheseregulations? ii. Havethereeverbeenproblemssuchasfakedrugs,smuggleddrugs,or drugsleakingfrompublichealthfacilities? iii. Whatchangestoregulationswouldyouliketosee? 10. Guidelinesfortreatingmalaria a. Whatarethemostuptodateguidelinesforthetreatmentofmalaria? b. Havethemostuptodateguidelinesbeenimplemented? c. Doyouhaveanyopinionsonthecurrentnationalguidelinesforthetreatmentof malaria(eitherforadultsorchildren,uncomplicatedorcomplicatedetc.)?For example: i. Canyoucommentontherelevanceofcurrentnationalguidelines? ii. Howwellaretheydisseminatedamongstprovidesoftreatment? iii. Dotheyimpacttheprescribinghabitsorotherwiseaffectdemandfor antimalarials? 11. OtherkeyfactorsaffectingantimalarialandRDTavailabilityandprice a. PleasecommentontheamountofcompetitionwithintheantimalarialandRDT marketatalllevelsofthesupplychain? b. Arethereanyinterventions/pilotsthatcouldaffecttheantimalarialorRDT markets? c. ArethereanyotherimportantfactorsthataffectantimalarialandRDT availabilityandpriceinthecountry? EndTime(hh:mm):

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainStudyInDepthInterview InformationSheet Mynameis__________________andIworkforLSHTMandPSI/Uganda.Withtheapproval of the Ministry of Health, we are conducting a study called the Supply Chain Study on the availability of antimalarial medicines throughout Uganda. You or one of your colleagues havealreadybeenvisitedbysomeofourteam,whowerecompletingaquestionnaireabout the antimalarials you stock. Many thanks for providing this information which has been extremely useful. We are now returning to a few businesses where we would like to ask somemoredetailedquestionsaboutyourantimalarialbusiness.Theresultsofthisstudywill be used to improve the availability of malaria treatment. I would like to invite you to participate in this study because we believe that your experience in the antimalarial businesscancontributemuchtoourunderstanding. Thequestionswillcover: Yoursuppliersandyourcustomers Yourdecisionsaboutantimalarialstockingandpricing Thecostsyouface Theregulatorysystem Wewilltakenotesduringtheinterview. Howlongwilltheinterviewtake? Theinterviewwithyoushouldtakeapproximately1hour. Arethereanydisadvantagesoradvantagesinvolvedintakingpart? There areno individualbenefitsto taking part, butinansweringour questionsyou willhelp improve our understanding of the antimalarial market, and so potentially benefit all Ugandans.Theonlydisadvantageforyouisthetimetocompletetheinterview. WhowillhaveaccesstotheinformationIgive? We are not here to inspect your business and no information about this specific outlet will be passed on to the regulatory authorities. The information gathered from this study is confidential and will be kept private. We will not share individual information about you with anyone beyond our research team. Instead, the knowledge gained from this research willbesharedinsummaryform,withoutrevealingindividualsidentities. WhatwillhappenifIrefusetoparticipate? Participation in this research is completely voluntary. You are freeto decide if you want to takepartinthisstudy.Ifyoudoagree,youcanstillchangeyourmindatanytime.Youcan refusetoansweranyspecificquestion,orstoptheinterviewatanypoint.Ifyouchoosenot to answer a question, stop the interview or not participate there will no be any negative implicationsforyou. WhatifIhaveanyquestions? Ifyou have any questions, you can ask themnow,duringthe interview orlater. If you wish toaskquestionslater,youmaycontactanyofthefollowingmembersofthestudyteam:

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
PeterBuyungo,ResearchDirector,PSIUganda,tel.+256312351100 SimonSensalire,DeputyResearchDirector,PSIUganda,tel.+256312351100 This proposal has been reviewed and approved by the Ethical Review Committee of Makerere University Medical School, which is a committee whose task is to make sure that researchparticipantsareprotectedfromharm.Forcontactspleasecall: Chairperson,EthicalReviewCommittee,MakerereMedicalSchool,tel+256414530020

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainStudyInDepthInterview CertificateofConsent I have read the information sheet for the above study to the interviewee of ______________ _________________ (business name) in a language he/she understands. He/shewasgiventheopportunitytoaskquestionsandseekclarification. Ibelievethathe/shegivesvoluntaryconsenttotakepartinthestudy. Signatureofresearcher_______________________ Date________________ Day/month/year Printnameofresearcher__________________________________________

10

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainStudyIndepthInterviews InterviewGuide InterviewDetails InterviewerName: InterviewDate(dd/mm/yyyy): StartTime(hh:mm): InterviewLocation: Informationformsprovided: Consentobtained EndTime(hh:mm):

yesorno yesorno

1) Introduction a) Canyoutellmeabitaboutyourselfandyourroleinthisbusiness? b) Whoaretheotherkeypeopleinvolvedinthebusinessandwhataretheirroles? 2) Relationshipswithyoursuppliers a) Howdoyoudecidewhichsupplierstobuyantimalarialsfrom? b) Doyoueverchangesuppliers?Why?Whynot? c) Doyoubuydirectfrommanufacturers/importers?Ifnot,whatstopsyou?(tryingto getatreasonsformultiplelinksinsupplychain) d) DoyoueverhaveproblemswithavailabilityofAMsupplies? e) Doyoursuppliershaveanyrulesabout: i) thepricesyoucanthenreselltheproductsat?(e.g.RRP)?DoyouthinkRRPsare observed? ii) theproductsyoupurchasefromthem(e.g.producttiein,bundling,exclusive dealing?) f) DoyoursuppliersdistributeAMstoyou?Ifyes,howoftendotheycome?Doyou preorderoraretheyvansales? g) Dosupplierssendsalesrepstovisityourbusiness?Whatinfluencedoesthathaveon yourbusiness? h) Areanyofyourstaffpaidforbysuppliershigherupthesupplychain(embedded salesforcebasedatlowerlevelsofthechain)? i) WhatotherwaysdoyoursupplierstrytoinfluencetheAMproductsyoustock? 3) Productsstocked a) [Whichmalariadrugsdoyouhaveinstock?(Probe:firstlineantimalarialtreatment, namesofbannedAM)startwiththisquestioninpilottest,butusuallythisinfo availablefromquantitativesurvey] b) HowdoyoudecidewhichAMtostock?Iftheydontstock[nameofACT/thefirstline treatmentdrug] c) Whydontyoustock[nameofACT/firstlinetreatmentdrug]?Whatwouldmakeyou stockit?

11

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
(followupdifferentpacksizes,shelflife,maxpriceatwhichtheywouldstock) 4) Settingprices a) HowdoyoudecidewhatpricestochargeforAM? b) Doyouvaryyourpriceofagivendrug?Whatarethereasonsforthis?(egorder value,differentcustomers?) c) Whatisyouraveragemarkup?Doesitvarybydrugclass?Whatistheantimalarial productwiththehighestmarkup?Withthelowestmarkup? 5) Relationshipswithyourcustomers a) Distribution:DoyoudistributeAMstoyourcustomersyourself?Why/whynot?If yes,canyoudescribeyourdistributionsystem?Doyouhavedistributioncentres/ nodes?(e.g.numberandfrequencyofroutes,chargingpractices,logistics) b) Doyousendsalesrepstoyoucustomers?(why/howoften,)] c) Doyouplaceanytypesofrestrictions(price,products)onyourpurchasers? d) Doyouhaveanyotherstrategiesforinfluencingyourowncustomerschoiceof product,orprovidingthemwithinformation? e) Doyoudoanyrepackaging/relabelingofAMs? 6) Competition a) Whichplacesdoyouconsideryourmaincompetitorsforcustomersfor antimalarials?Whatisitaboutthemthatmakesthemyourcompetitors? b) Howdoyoutrytoattractmorecustomerstoyourbusiness? c) Whydoyouthinksomecustomerschooseotherbusinessesinsteadofyours? d) Arethereanywaysinwhichbusinessescooperate?e.g.Tradeassociations?(areyou amember?Whatbenefit?)Agreementsaboutwhatpricestocharge? Territory/geographicareatofocusbusinesson? 7) SourcesofInformation a) Howdoyougetinformationaboutdrugs? 8) Salesrevenue a) Whatisyourgrossmonthlysalesrevenue? b) Whatshareofthisisfromantimalarialdrugs? c) Whattimesofyearisithigh/low?Howdoestherevenuesharevaryatthesetimes? 9) CostsinvolvedinwholesalingandretailingAM a) Weretryingtounderstandthemaincostsofrunningapharmacybusiness:Could youpleasehelpustocompletethistable: Expense UShpermonth Notes Rent Electricity Stock Water

12

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
Phone Employees:Salaried Employees:Casual/hourly Stationery Freight Clearancecharges Marketing Licenses(pharmaceutical, Thismaybeannual trade) NDAfees Insurance Security TaxesCorporate TaxesLocal Taxesother Othercategories Total b) Arethereanyimportantcategoriesthatwehavemissed? c) [Checkbycomparingthetotalrevenuewithtotalcost]Sothatmeansthatyour monthlyprofitis__________? d) Ifyouweretosetupthisbusinessagaintoday,whatwouldbethecostsofsetting up? i) Furnitureandfittings ii) Purchaseofinitialstock iii) Equipment iv) Vehicles e) Howdoyoufinanceyourinventory?Doyouhaveanyproblemswiththis? 10) Regulations a) Whatareyourviewsontheregulatoryrequirementsforthistypeofbusiness? i) Doyouthinktheyarereasonable?Ifnot,whynot? ii) Howdotheyinfluencethewayyourunthebusiness? b) Whatareyourviewsonthecapacityoftheregulatorstoenforcetheirregulations? i) Doyoufeelthatmostpeoplecomply? ii) Doyoufeelthatsanctionsareenforced? iii) Haveyouhadanypersonalexperiencesofdealingwiththeregulatory authorities?Canyoudescribethem? c) Wouldyouliketoseechangesintheregulatorysystem?Whataspectswouldyou liketoseechanging? d) Inplaceswehavecomefromwehaveheardstoriesaboutdrugsfromhealth facilities/thepublicsector/publiccentralmedicalstoregettingintoprivateshops. Haveyoueverheardstoriessuchasthese? e) Whatdoyouknowabouttheoperationofablack/parallelmarketinthiscountry (=unofficialimports/exports,smuggling) 11) PolicyContext
13

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
a) Askaboutanypolicyinterventionoccurringinagivensetting(e.g.MMVpilot) b) Howisitaffectingyourbusiness?themarketasawhole? 12) Suggestions a) Whatisthebiggestrisk/challengeyoufaceintheAMbusiness?Whatcouldbedone toaddressthis? b) Isthereanythingelsethatyouwanttotellmeaboutyourexperienceindealingwith antimalarials? c) Doyouhaveanyquestionsforus? 13) Recordothernotesandimpressionsontheinterview.

14

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
Town: Wearetryingtodevelopacompletelistofallbusinessesthatwholesaleantimalarialsormalariadiagnostictestkitsinthistown. Istheinformationprovidedinthetablebelowcomplete?Doyouknowofotherbusinessesofthiskindinthistownandwhicharenotlisted? Ifanyadditionalbusinessesidentified,completeintablebelow: Completewhenyouarriveatnewoutlet Completeatsourceoutlet,andverifywhenyouarriveatnewoutlet Nameofbusiness Physicaladdressorlocationidentifiers Phonenumber EngagesinAM EngagesinRDT Typeof Wholesale? Wholesale? business (Y/N) (Y/N) (drug/general)

15

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainSurvey InformationSheet Mynameis__________________andIworkforLSHTMandPSI/Uganda.Withtheapproval of the Ministry of Health, we are conducting a study called the Supply Chain Study on the availability of antimalarial medicines throughout Uganda. The results of this study will be used to improve the availability of malaria treatment. I would like to invite you to participate in this study because we believe that your experience in the antimalarial businesscancontributemuchtoourunderstanding. Iwouldliketoaskyouanumberofquestionsabout: Theoperationofyourbusiness Thetypeofmedicinesyoustock Yoursuppliersandyourcustomers In addition, I would like to ask your permission to see what antimalarial medicines you stock.FinallywewouldliketorecordyourgeographicalcoordinatesusingaGPSmachine. Howlongwilltheinterviewtake? The interview with you shouldtakeapproximately 45minutesto 1hour,depending onhow manyantimalarialmedicinesyouhaveinstock. Arethereanydisadvantagesoradvantagesinvolvedintakingpart? There areno individualbenefitsto taking part, butinansweringour questionsyou willhelp improve our understanding of the antimalarial market, and so potentially benefit all Ugandans.Theonlydisadvantageforyouisthetimetocompletetheinterview. WhowillhaveaccesstotheinformationIgive? We are not here to inspect your business and no information about this specific outlet will be passed on to the regulatory authorities. The information gathered from this study is confidential and will be kept private. We will not share individual information about you with anyone beyond our research team. Instead, the knowledge gained from this research willbesharedinsummaryform,withoutrevealingindividualsidentities. WhatwillhappenifIrefusetoparticipate? Participation in this research is completely voluntary. You are freeto decide if you want to takepart in this study.Ifyoudoagree,you canstillchange yourmind atanytime.You can refuse to answer any specific question, or stop the interview at any point. If you chose not to answer a question, stop the interview or not participate there will no be any negative implicationsforyou. WhatifIhaveanyquestions? Ifyou have any questions, you can ask themnow,duringthe interview orlater. If you wish toaskquestionslater,youmaycontactanyofthefollowingmembersofthestudyteam: PeterBuyungo,ResearchDirector,PSIUganda,tel.+256312351100

16

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SimonSensalire,DeputyResearchDirector,PSIUganda,tel.+256312351100 This proposal has been reviewed and approved by the Ethical Review Committee of Makerere University Medical School, which is a committee whose task is to make sure that researchparticipantsareprotectedfromharm.Forcontactspleasecall: Chairperson,EthicalReviewCommittee,MakerereMedicalSchool,tel+256414530020

17

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SupplyChainSurvey CertificateofConsent I have read the information sheet for the above study to the interviewee of ______________ _________________ (business name) in a language he/she understands. He/shewasgiventheopportunitytoaskquestionsandseekclarification. Ibelievethathe/shegivesvoluntaryconsenttotakepartinthestudy. Signatureofresearcher_______________________Date________________ Day/month/year Printnameofresearcher__________________________________________

18

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
SectionI:Census&ScreeningInformation Interviewercompletesthissectionforallbusinesses. DistrictBusinessID:[__|__|__][__|__|__] BusinessID C1.Todaysdate(dd/mm/yy) [__|__][__|__][0|__] C2.Interviewersname C2a.Interviewerscode [________________________________________] [___|___|___] C3.Province C3a.Provincecode [________________________________________] [___|___|___] C4.District C4a.Districtcode [________________________________________] [___|___|___] C5.Nameofbusiness(ifnoname,recordnoname) C5a.Businesscode [________________________________________] [___|___|___] SCREENINGQUESTIONS S1.Doyouhaveanyantimalarialmedicinesinstocktoday? 1=YesgotoS3 [___] 2=No 9=Dontknow S2.Ifno,haveyoustockedanyantimalarialsinthepast3months? 1=Yes [___] 2=No 9=Dontknow S3.Doyouhaveanyrapiddiagnostictestkitsformalariainstocktoday? 1=Yesobtainconsent [___] 2=No 9=Dontknow S4.Ifno,haveyoustockedanyRDTsinthelast3months? 1=Yes [___] 2=No 9=Dontknow IFANSWEREDNOORDONTKNOWTOALL4OFTHEABOVEQUESTIONS ENDINTERVIEWOTHERWISEOBTAINCONSENT

19

ITEMSHIGHLIGHTEDINYELLOWARECOUNTRYSPECIFIC
C6.NumberofVisits Visit1 Visit2 Visit3 Date (dd/mm/yy) [__|__][__|__][_0_|__] [__|__][__|__][_0_|__] [__|__][__|__][_0_|__] Result [__] [__] [__] 1=Completed 2=Businesscloseddown 3=Eligiblerespondentnotavailable 4=Businessnotopenatthetime 5=Interviewinterrupted 6=RefusedgotoC7 7=Other: [__________________________________________________________________] Ifitwillbepossibletocompletetheinterviewatanothertime,notethistimehere,and returnthen: __________________________________________________________________________ REFUSAL: C7.Ifthebusinessrefused,why? 1=Clientload [__] 2=Thinksitsaninspection/nervousaboutlicense 3=Notinterested 4=Refusestogivereason 5=Other(Describe)[____________________________________________] C8.Anyothercomments:

20

DistrictBusinessID:[__|__|__][__|__|__] II.ProviderQuestionnaire T1.TimeStarted P1.Inwhatyeardidthesepremisesopen(yyyy)? 9999=Dontknow P2.Apartfromantimalarials,whatotherdrugcategoriesareinstock? Readlist 1=Yes 2=No 9=Dontknow I. Painkillers/antipyretics II. Antihelminthics(worms) III. Antibiotics IV. Oralantifungals V. Cardiovascular(angina,arrhythmia,hypertension) VI. Ointmentsandcreams(antifungal,acne) VII. GastroIntestinalconditions(antacid,antiemetic,laxatives, diarrheas) VIII. Vitaminsandtonics IX. Coughmedicines P3.Apartfrompharmaceuticalproducts,whatothertypesofproductsdo yousellinthisbusiness?Readlist 1=Yes 2=No 9=Dontknow I. Toiletries II. Householdgoods III. Mobileairtime IV. Cigarettes V. Food Other(specify):[_______________________________] P4.Whoareyourcustomersforantimalarials?Readlist 1=Yes 2=No 8=Refuses 9=Dontknow I. Retailcustomers(individuals) II. Pharmacy/drugstore III. Generalretailer IV. PublicClinic/healthcentre/dispensary V. PrivateClinic/healthcentre/dispensary VI. PublicHospital VII. PrivateHospital

[__|__:__|__]
[___|___|___|___]

[___] [___] [___] [___] [___] [___] [___] [___] [___]

[___] [___] [___] [___] [___] [___] [___] [___] [___] [___] [___] [___] [___]

21

DistrictBusinessID:[__|__|__][__|__|__] VIII. Drugwholesaler IX. Generalwholesaler X. Other(specify):[_______________________________] [___] [___] [___]

P5.Wheredoyourcustomerscomefrom? 1=Yes 2=No 9=Dontknow I. Listofregions/province/states/etc. [___] II. Othercountries(specify):[_________________________________] [___] [_________________________________] [_________________________________] P6.Doyouimportantimalarials? 1=Yes [___] 2=No 9=Dontknow P7.Doestheownerofthisbusinessownothershopsorbusinesses? 1=Yes [___] 2=NogotoP9 9=DontknowgotoP9 P8.Ifyes,howmanyofeachthefollowingtypesofbusinessesdoeshe/sheown? TypeofBusiness Number Location 1=Thistown (write#) 2=Othertowninthis country 3=Both 4=Other(specify) 9=Dontknow I. General [___|___|___] [___] wholesaler/distributor/importer II. Drug [___|___|___] [___] wholesaler/distributor/importer III. Drugwholesaleandretailstore [___|___|___] [___] IV. Generalwholesaleandretailstore V. Retailpharmacy/drugstore VI. Generalretailer VII. Manufacturer VIII. Clinic IX. Other(specify): [___|___|___] [___] [___|___|___] [___] [___|___|___] [___] [___|___|___] [___] [___|___|___] [___]

[___|___|___] [___] P9.Howareantimalarialstransportedtoyourcustomers? 1=Youdelivertothem

[___]

22

DistrictBusinessID:[__|__|__][__|__|__] 2=Theycollectfromyou 3=Both 9=Dontknow P10.Inthelastthreemonths,haveyougivencredittoanywholesale customerswhoboughtantimalarials? [___] 1=Yes 2=NogotoquestionP12 9=DontknowgotoquestionP12 P11.Ifyes,whatareyourmostcommontermsofwholesalecredit(i.e.how [___|___|___] manydays)?Enternumberofdays 999=Dontknow P12.Includingtheownerandyourself,howmanypeopleworkhere(all staff)? [___|___|___] 999=Dontknow P13.Hasanybodyworkinginthisbusiness(includingtheowner)completed secondaryschool? [___] 1=YesgotoP15 2=No 9=Dontknow P14.Ifnoordontknow,hasanybodyworkinginthisbusiness(includingthe [___] owner)completedprimaryschool? 1=Yes 2=NogotoquestionP17 9=DontknowgotoquestionP17 P15.Doesanyoneworkinginthisbusiness[includingtheowner]haveany [___] healthrelatedqualifications? 1=Yes 2=NogotoquestionP17 9=DontknowgotoquestionP17 P16.Howmanypeopleworkinginthisbusiness[includingtheowner]havethefollowingtypes ofhealthqualifications?ReadList TypeofHealthQualification Number I. Pharmacist [___] II. Pharmacytechnician [___] III. Pharmacyassistant IV. Medicaldoctor V. Nurse/Midwife VI. ClinicalOfficer VII. Other(Describe): [___] [___] [___] [___] [___]

23

DistrictBusinessID:[__|__|__][__|__|__]

P17.Inthepast2years,havethestaffthatworkhereparticipatedinany typeofinservicetrainingorworkshops?Donotincludepreservice training 1=Yes 2=NogotoP19 9=DontknowgotoP19 P18.Ifyes,completethefollowingtable: Subjectoftraining: Runby: 1=Government 2=NGO 3=Private/commercial 9=Dontknow [___] [___]

[___]

Duration: (indays)

[___|___] [___|___] [___|___]

[___] SOURCESOFANTIMALARIALS P19.Inthelast3months,fromhowmanysuppliershaveyoupurchased antimalarials? 00=Nosuppliersinlast3monthsgotoP37 88=Refuses 99=Dontknow P20.Inthepast3months,whatwasthenameofyourtopsupplierof antimalarials? 1=Knowsnameofbusiness(specify): [_________________________________________________] 8=RefusesgotoP37 9=DontknowgotoP37 P21.Town(ofthetopsupplier) 1=Knowstown(specify):[_______________________________] 8=Refuses 9=Dontknow P22.Physicaladdressorlocationidentifiers(ofthetopsupplier) 1=Knowsaddress(specify):[____________________________] 8=Refuses 9=Dontknow P23.Telephonenumber(ofthetopsupplier) 1=Knowstelephonenumber(specify):[____________________] 8=Refuses 9=Dontknow

[___|___]

[___]

[___]

[___]

[___]

24

DistrictBusinessID:[__|__|__][__|__|__] P24.Typeofsupplier.Readlist.Singleresponse. 1=Generalwholesaler/importer 2=Drugwholesaler/importer 3=Pharmacy/drugstore 4=Manufacturer 5=Other(specify):[_______________________________] 8=Refuses 9=Dontknow P25.Howdoyoureceiveyourantimalarialsfromyourtopsupplier?Read list.Oneresponseonly. 1=Supplierdeliverstoyou 2=Youcollectfromsupplier 3=Both 8=Refuses 9=Dontknow P26.Doyoubuyantimalarialsmedicinesoncreditfromyourtopsupplier? 1=Yes 2=NogotoquestionP28 9=DontknowgotoquestionP28 P27.Whatarethemostcommontermsofcreditfromyourtopsupplier? Enternumberofdays 999=dontknow P28.Didyouhaveanyothersuppliersforantimalarialsinthepastthree months? 1=Yes 2=NogotoquestionP37 9=DontknowgotoquestionP37 P29.Inthelast3months,whatwasthenameofyoursecondtopsupplier forantimalarials? 1=Knowsnameofbusiness(specify): [_________________________________________________] 8=Refuses 9=Dontknow P30.Town(ofthesecondsupplier) 1=Knowstown(specify):[______________________________] 8=Refuses 9=Dontknow P31.Physicaladdressorlocationidentifiers(ofthesecondsupplier) 1=Knowsaddress(specify):[____________________________] 8=Refuses 9=Dontknow P32.Telephonenumber(ofthesecondsupplier) 1=Knowstelephonenumber(specify):[____________________] 8=Refuses 9=Dontknow [___]

[___]

[___]

[___|___|___] [___]

[___]

[___]

[___]

[___]

25

DistrictBusinessID:[__|__|__][__|__|__] P33.Typeofsupplier.Readlist.Singleresponse. 1=Generalwholesaler/importer [___] 2=Drugwholesaler/importer 3=Pharmacy/drugstore 4=Manufacturer 5=Other(specify):[_______________________________] 8=Refuses 9=Dontknow P34.Howdoyoureceiveyourantimalarialsfromyoursecondtopsupplier? Readlist.Oneresponseonly. [___] 1=Supplierdeliverstoyou 2=Youcollectfromsupplier 3=Both 8=Refuses 9=Dontknow P35.Doyoubuyantimalarialsmedicinesoncreditfromyoursecondtop [___] supplier? 1=Yes 2=NogotoquestionP37 9=DontknowgotoquestionP37 P36.Whatarethemostcommontermsofcreditfromyoursecondtop supplier?Enternumberofdays [___|___|___] 999=Dontknow

26

DistrictBusinessID:[__|__|__][__|__|__] REGISTRATIONSTATUS P37.Doyouhavealicenseorregistrationfromthepharmacyboard/NDA? TypeofLicense Has Observed ValidUntil(mm/yy) License 1=Yes 77/77=N/A 2=No 8=Refuses 9=Dontknow I. Wholesalepharmacylicense [___] [___] [___|___]/[___|___] II. Retailpharmacylicense III. Wholesaleandretailpharmacylicense IV. Pharmacyimporterlicense V. Pharmacyexporterlicense VI. Pharmacymanufacturerlicense [___] [___] [___] [___] [___] [___] [___] [___] [___] [___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___]

VII. Other(describe): [___] [___] [______________________________] P38.Doyouhaveabusinessortradinglicenseorregistration? TypeofLicense Has Observed License 1=Yes 2=No 8=Refuses 9=Dontknow I. Wholesalebusinesslicense [___] [___] II. Retailbusinesslicense III. Wholesaleandretailbusinesslicense IV. Manufacturerlicense V. Importerslicense VI. Tradinglicense [___] [___] [___] [___] [___] [___] [___] [___] [___] [___]

IssueDate(mm/yy) 77/77=N/A

[___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___] [___|___]/[___|___]

VII. Other(describe): [___] [___] [___|___]/[___|___] [______________________________] P39.Hasagovernmentpharmaceuticalinspectorcometovisityouin thelastyear? [___] 1=Yes 2=NogotoquestionP41 9=DontknowgotoquestionP41 P40.Whendidtheylastcome?Enterdate(MM/YY) [___|___]/[___|___] P41.Canyoupleaseshowusthefullrangeofantimalarialsthatyoucurrentlyhaveinstock.Do
27

DistrictBusinessID:[__|__|__][__|__|__] youcurrentlyhaveanyofthefollowing:(Noresponsesneedtoberecorded) I. Artemisinincombinationstherapies VII. Proguanil II. Artemisininmonotherapies VIII. Chloroquine III. SP IX. Syrups/suspensions IV. Amodiaquine X. Injectibles V. Quinine XI. Granules/powders VI. Mefloquine P42.Oftheseproducts,whichistheantimalarialproductthatyouhavesoldthemostdosesof (treatmentcourses)inthepastmonth? Genericname Brandname Dosageform 9=Dontknow 6=Nopreference 1=Tablet 6=Powderinjectable 9=Dontknow 2=Suppository 7=Granule 3=Syrup 8=Other(describe) 4=Suspension 9=Dontknow 5=Liquidinjectable [___] P43.Inyouropinionfortreatinguncomplicatedmalariainadults,whatisthemosteffective antimalarialproductofallofthoseavailableonthemarket?Lookingforeithergeneric nameorbrandname. Genericname Brandname Dosageform 9=Dontknow 6=Nopreference 1=Tablet 6=Powderinjectable 9=Dontknow 7=Granule 2=Suppository 8=Other(describe) 3=Syrup 9=Dontknow 4=Suspension 5=Liquidinjectable [___] Donotwritehere Donotwritehere [___|___] [___|___|___] Donotwritehere Donotwritehere [___|___] [___|___|___]

28

DistrictBusinessID:[__|__|__][__|__|__] P44.Inyouropinionfortreatinguncomplicatedmalariainchildrenunderfiveyearsofage, whatisthemosteffectiveantimalarialproductofallofthoseavailableonthemarket? Lookingforeithergenericnameorbrandname. Genericname Brandname Dosageform 9=Dontknow 6=Nopreference 1=Tablet 6=Powderinjectable 9=Dontknow 2=Suppository 7=Granule 3=Syrup 8=Other(describe) 4=Suspension 9=Dontknow 5=Liquidinjectable [___] Donotwritehere Donotwritehere [___|___] [___|___|___] [___]

P45.Pleasenamethemedicinerecommendedbythegovernmenttotreat uncomplicatedmalaria?Donotreadlist.Onlyoneresponseallowed. 1=ArtemetherLumefantrine(AL)/Coartem 2=SP 3=Artemisininmonotherapy 4=Amodiaquine 5=Quinine 6=Artesunate/amodiaquine 7=Chloroquine 8=Other(specify):[_______________________________] 9=Dontknow

29

DistrictBusinessID:[__|__|__][__|__|__] III.AntimalarialInventorySheets Proceedtothedruginventory.DifferentDrugInventorysheetswillbeusedtorecordthe antimalarialinformationbasedonthedosageformofthemedicine.Lookatthetopofeach sheettorecordthedruginformationontheappropriateform: Iftheantimalarialisintheformoftabletsorsuppositories,usetheTablets& SuppositoriesDrugInventorySheet. Iftheantimalarialisinanyformotherthantabletsorsuppositories,usetheNon TabletDrugInventorySheet. AtthebottomofeachInventorysheet,numbereachcompletedside. P46.Interviewer:Wereanyoftheantimalarialsrecordedintheinventory ACTs? [___] 1=YesgathersamplesofallACTproductscurrentlyinstock 2=NogotoquestionP49 P47.Inthepast3months,haveyoueverbeenoutofstockofallthese antimalarials(showallgatheredACTs)atthesametime? [___] 1=Yes 2=NogotoquestionP49 8=RefusesgotoquestionP49 9=DontknowgotoquestionP49 P48.Atthetimeyouwereoutofstockofalloftheseantimalarials(showall [___] gatheredACTs),didyouhaveanyotherACTsinstock? 1=Yes,specify[______________________________] 2=No 8=Refuses 9=Dontknow OBSERVATIONRECORD P49.MayIseewhereyoustoreyourantimalarials? 1=Yes [___] 2=No,notstoredonthesepremisesgotoP52 8=RefusesgotoP52 P50.Areantimalarialsstoredinadryarea? 1=Yes,storedinadryarea [___] 2=No,notstoredinadryarea P51.Areantimalarialsprotectedfromdirectsunlight? 1=Yes,protectedfromdirectsunlight [___] 2=No,notprotectedfromsunlight P52.Areantimalarialskeptonthefloor? 1=Yes,keptonthefloor [___] 2=No,notkeptonthefloor

30

DistrictBusinessID:[__|__|__][__|__|__] SOURCESOFRDTs IfthebusinesseitherhasRDTscurrentlyinstockORhascarriedtheminthelast3months, completethissection;otherwise,proceedtoC9 P53.Inthelastthreemonths,fromhowmanysuppliershaveyoupurchased [___|___] rapiddiagnostictests(RDTs)formalaria? 00=Nosuppliersinlast3monthsgotoRDTInventorySheetif hasRDTsinstock;otherwisegotoC9 88=Refuses 99=Dontknow P54.Inthepastthreemonths,whatwasthenameofyourtopsupplierof [___] RDTs? 1=Knowsnameofbusiness(specify): [________________________________________________] 8=RefusesgotoRDTInventorySheetifhasRDTsinstock; otherwisegotoC9 9=DontknowgotoRDTInventorySheetifhasRDTsinstock; otherwisegotoC9 P55.Town(ofthetopsupplier) 1=Knowstown(specify):[_______________________________] [___] 8=Refuses 9=Dontknow P56.Physicaladdressorlocationidentifiers(ofthetopsupplier) 1=Knowstown(specify):[______________________________] [___] 8=Refuses 9=Dontknow P57.Telephonenumber(ofthetopsupplier) 1=Knowstelephonenumber(specify):[____________________] [___] 8=Refuses 9=Dontknow P58.Typeofsupplier.Readlist.Singleresponse. 1=Generalwholesaler/importer [___] 2=Drugwholesaler/importer 3=Pharmacy/drugstore 4=Manufacturer 5=Other(describe):[_______________________________] 8=Refuses 9=Dontknow P59.HowdoyoureceiveyourRDTsfromyourtopsupplier?Readlist.One [___] responseonly. 1=Supplierdeliverstoyou 2=Youcollectfromsupplier 3=Both 8=Refuses 9=Dontknow

31

DistrictBusinessID:[__|__|__][__|__|__] P60.DoyoubuyRDTsmedicinesoncreditfromyourtopsupplier? 1=Yes 2=NogotoquestionP61 9=DontknowgotoquestionP61 P61.Whatarethemostcommontermsofcreditfromyourtopsupplier? Enternumberofdays 999=Dontknow P62.DidyouhaveanyothersuppliersforRDTsinthepastthreemonths? 1=Yes 2=NogotoRDTInventorySheetifhasRDTsinstock;otherwise gotoC9 9=DontknowgotoRDTInventorySheetifhasRDTsinstock; otherwisegotoC9 P63.Inthelast3months,whatwasthenameofyoursecondtopsupplier forRDTs? 1=Knowsnameofbusiness(specify) [___________________________________________________] 8=RefusesgotoRDTInventorySheetifhasRDTsinstock; otherwisegotoC9 9=DontknowgotoRDTInventorySheetifhasRDTsinstock; otherwisegotoC9 P64.Town(ofthesecondsupplier) 1=Knowstown(specify):[____________________________] 8=Refuses 9=Dontknow P65.Physicaladdressorlocationidentifiers(ofthesecondsupplier) 1=Knowsaddress(specify):[____________________________] 8=Refuses 9=Dontknow P66.Telephonenumber(ofthesecondsupplier) 1=Knowstelephonenumber(specify):[____________________] 8=Refuses 9=Dontknow P67.TypeofsupplierReadlist.Singleresponse. 1=Generalwholesaler/importer 2=Drugwholesaler/importer 3=Pharmacy/drugstore 4=Manufacturer 5=Other(describe):[_______________________________] 8=Refuses 9=Dontknow P68.HowdoyoureceiveyourRDTsfromyoursecondtopsupplier?Read list.Oneresponseonly. 1=Supplierdeliverstoyou 2=Youcollectfromsupplier 3=Both 8=Refuses 9=Dontknow [___]

[___|___|___] [___]

[___]

[___]

[___]

[___]

[___]

[___]

32

DistrictBusinessID:[__|__|__][__|__|__] P69.DoyoubuyRDTsmedicinesoncreditfromyoursecondtopsupplier? 1=Yes 2=NogotoRDTInventorySheetifhasRDTsinstock;otherwise gotoC9 9=DontknowgotoRDTInventorySheetifhasRDTsinstock; otherwisegotoC9 P70.Whatarethemostcommontermsofcreditfromyoursecondtop supplier?Enternumberofdays 999=Dontknow [___]

[___|___|___]

33

DistrictBusinessID:[__|__|__][__|__|__] IV.RDTInventorySheet ProceedtotheRDTinventory.Useasmanysheetsasnecessary. AtthebottomofeachInventorysheet,numbereachcompletedside.

34

DistrictBusinessID:[__|__|__][__|__|__] C9.Physicaladdressofbusiness(notPObox) C9a.Telephone GPS: [____________________] [____________________] [____________________] C10. South: Latitude reading C11.East: Longitude [____________________] [____________________] [____________________] reading COMPLETEDSNOWBALLCENSUSSURVEY?F Thankyouverymuchforyourparticipation. Doyouhaveanyquestionsorcommentsforus? T2.TimeCompleted ReturntoC6torecordfinalstatusofinterview ENDINTERVIEW X2.Additionalobservationsbyinterviewer(ifany) A1.TotalnumberofTablet&SuppositoryInventorySheets A1a.TotalnumberofTablet&SuppositoryProductsInventoried A2.TotalnumberofNonTablet&SuppositoryInventorySheets A3.TotalnumberofRDTInventorySheets A3a.TotalnumberofRDTProductsInventoried

[__|__:__|__]

[___|___] [___|___] [___|___] [___|___] [___|___]

35

TABLET&SUPPOSITORYDRUGINVENTORYSHEET(TS)
1.Genericname Donotwritehere [__|__] 4.Brandname

DISTRICTBUSINESSID:[__|__|__][__|__|__]
7.Amountsold wholesaleinlast week (Record#ofpacks/ pots/tinsdescribedin Q6) Thisbusinesssold [__|__|__|__|__|__] packs/pots/tinsin thelastweek 8.WholesaleSellingprice Whatistheminimumquantity(i.e.numberof packs)thatyouwholesale? [__|__|__|__|__]packsatapriceperpackof [__|__|__|__|__]sh Whatistheminimumpriceyouchargeforbulk purchases? [__|__|__|__|__]sh Howmanypackswouldyourcustomerhaveto purchasetoreceivethisprice? [__|__|__|__|__]packs 88888=Notapplicable(doesnotvaryprice) 99999=Dontknow 8.WholesaleSellingprice Whatistheminimumquantity(i.e.numberof packs)thatyouwholesale? [__|__|__|__|__]packsatapriceperpackof [__|__|__|__|__]sh Whatistheminimumpriceyouchargeforbulk purchases? [__|__|__|__|__]sh Howmanypackswouldyourcustomerhaveto purchasetoreceivethisprice? [__|__|__|__|__]packs 88888=Notapplicable(doesnotvaryprice) 99999=Dontknow 9.Purchaseprice Forthemostrecentpurchase,you boughtatotalof [__|__|__|__|__]packs foraunitpriceof [__|__|__|__|__|__]sh

2.Strength [__|__|__]mg [__|__|__]mg

3.Dosageform 1=Tablet 2=Suppository [__]

5.Countryof manufacture

Donotwritehere [__|__|__] 1.Genericname Donotwritehere [__|__] 4.Brandname

6.Packagesize (Fillinnumber) Thereisatotalof [__|__|__|__]tablets/ suppositoriesineach (selectpackagetype): 1=Pot/tin 2=Pack [__] 3.Dosageform 1=Tablet 2=Suppository [__]

2.Strength [__|__|__]mg [__|__|__]mg

5.Countryof manufacture

Donotwritehere [__|__|__]

6.Packagesize (Fillinnumber) Thereisatotalof [__|__|__|__]tablets/ suppositoriesineach (selectpackagetype): 1=Pot/tin 2=Pack [__]

7.Amountsold wholesaleinlast week (Record#ofpacks/ pots/tinsdescribedin Q6) Thisbusinesssold [__|__|__|__|__|__] packs/pots/tinsin thelastweek

9.Purchaseprice Forthemostrecentpurchase,you boughtatotalof [__|__|__|__|__]packs foraunitpriceof [__|__|__|__|__|__]sh

Tablet&SuppositoryInventorySheet[__|__]of[__|__]

36

NONTABLETDRUGINVENTORYSHEET(NT):SYRUP,SUSPENSION,LIQUID&POWERINJECTABLE,GRANULE&OTHERS
1.Genericname Donotwritehere [__|__]

DistrictBusinessID:[__|__|__][__|__|__]
8.Wholesalesellingprice Whatistheminimumquantity(i.e.numberof packs)thatyouwholesale?

2.Strength [__|__|__]mg/[__|__|__]mL [__|__|__]mg/[__|__|__]mL (Note:nomLrecordedfor powdersorgranules) 5.Countryof manufacture

3.Dosageform 3=Syrup 4=Suspension 5=Liquidinjectable 6=Powderinjectable 7=Granule

4.Brandname

[__] 6a.Unitsize(Fillinnumber) Totalof[__|__|__|__]mL(ormgforpowder, injectionsandGranules)ineach:

7.Amountsoldwholesaleinlast week (Record#ofpacks/pots/tinsdescribed inQuestion6) Thisbusinesssold [__|__|__|__|__|__]packs/pots/tins inthelastweek 9.Purchaseprice Forthemostrecentpurchase,you boughtatotalof [__|__|__|__|__]packs foraunitpriceof [__|__|__|__|__|__]sh

1=Bottle 2=Ampoule/vial 3=Sachetofgranules

Donotwritehere [__|__|__]

[__] 6b.Packagesize(Fillinnumber)

Totalof[__|__|__|__]unitsperpackage

[__|__|__|__|__]packsatapriceperpackof [__|__|__|__|__]sh Whatistheminimumpriceyouchargeforbulk purchases? [__|__|__|__|__]sh Howmanypackswouldyourcustomerhaveto purchasetoreceivethisprice? [__|__|__|__|__]packs 88888=Notapplicable(doesnotvaryprice) 99999=Dontknow

1.Genericname
Donotwritehere [__|__]

2.Strength [__|__|__]mg/[__|__|__]mL [__|__|__]mg/[__|__|__]mL (Note:nomLrecordedfor powdersorgranules) 5.Countryof manufacture

3.Dosageform 3=Syrup 4=Suspension 5=Liquidinjectable 6=Powderinjectable 7=Granule

4.Brandname

[__] 6a.Unitsize(Fillinnumber) Totalof[__|__|__|__]mL(ormgforpowder, injectionsandGranules)ineach:

7.Amountsoldwholesaleinlast week (Record#ofpacks/pots/tinsdescribed inQuestion6) Thisbusinesssold [__|__|__|__|__|__]packs/pots/tins inthelastweek 9.Purchaseprice Forthemostrecentpurchase,you boughtatotalof [__|__|__|__|__]packs foraunitpriceof [__|__|__|__|__|__]sh

8.Wholesalesellingprice Whatistheminimumquantity(i.e.numberof packs)thatyouwholesale?

1=Bottle 2=Ampoule/vial 3=Sachetofgranules

Donotwritehere [__|__|__]

[__] 6b.Packagesize(Fillinnumber)

Totalof[__|__|__|__]unitsperpackage

[__|__|__|__|__]packsatapriceperpackof [__|__|__|__|__]sh Whatistheminimumpriceyouchargeforbulk purchases? [__|__|__|__|__]sh Howmanypackswouldyourcustomerhaveto purchasetoreceivethisprice? [__|__|__|__|__]packs 88888=Notapplicable(doesnotvaryprice) 99999=Dontknow

NonTabletInventorySheet[__|__]of[__|__]

37

RAPID DIAGNOSTIC TEST INVENTORY SHEET (RDT)

1.Brandname Donotwritehere [__|__|__] 2.Manufacturer Donotwritehere [__|__] 3.Countryofmanufacture 1.Brandname Donotwritehere [__|__|__] 2.Manufacturer Donotwritehere [__|__] 3.Countryofmanufacture

DistrictBusiness ID: [__|__|__][__|__|__]

4.Quantityinstock (Recordtotal#oftests) Thereare [__|__|__|__|__]tests

5.WholesaleSellingprice Whatistheminimumquantity(numberoftests)thatyouwholesale?

[__|__|__|__|__]testsatapricepertestof[__|__|__|__|__]sh

Whatistheminimumpriceyouchargeforbulkpurchases?

6.Purchaseprice Forthemostrecent purchase,youboughtatotal of

[__|__|__|__|__]sh

Howmanytestswouldyourcustomerhavetopurchasetoreceivethis price?

[__|__|__|__|__]tests foraunitpriceof

[__|__|__|__|__|__]sh

[__|__|__|__|__|__]tests 88888=Notapplicable(doesnotvaryprice) 99999=Dontknow

4.Quantityinstock (Recordtotal#oftests) Thereare [__|__|__|__|__]tests

5.WholesaleSellingprice Whatistheminimumquantity(numberoftests)thatyouwholesale?

[__|__|__|__|__]testsatapricepertestof[__|__|__|__|__]sh

Whatistheminimumpriceyouchargeforbulkpurchases?

6.Purchaseprice Forthemostrecent purchase,youboughtatotal of

[__|__|__|__|__]sh

Howmanytestswouldyourcustomerhavetopurchasetoreceivethis price?

[__|__|__|__|__]tests foraunitpriceof

[__|__|__|__|__|__]sh

[__|__|__|__|__|__]tests 88888=Notapplicable(doesnotvaryprice) 99999=Dontknow

RDTInventorySheet[__|__]of[__|__]
38